Patrick Moriarty

Patrick Moriarty has extensive experience in business development within the pharmaceutical and healthcare sectors, having served as Executive Director of Business Development at Merck from April 2018 to May 2020. Prior to this role, Patrick held positions at Early Harvest Management, LP as Director of Business Development in Oncology, and at HealthCor Management as a Senior Analyst. Earlier in career, Patrick worked as an Analyst at Fortis and UBS, where responsibilities included financial analysis and strategic planning. Educationally, Patrick holds an MBA in Finance and Quantitative Finance from NYU Stern School of Business and a PhD in Clinical Psychology from Hofstra University.